| |
| |
|
| Insider
Information: |
Haurwitz Rachel E. |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
188,137 |
|
|
Indirect Shares
|
8,943,241 |
|
|
| Direct
Value |
$561,798 |
|
|
|
Indirect Value
|
$148,682,331 |
|
|
| Total
Shares |
9,131,378 |
|
|
| Total
Value |
$149,244,129 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intellia Therapeutics, Inc. |
NTLA |
Director, 10% Owner |
2016-05-11 |
0 |
2016-05-11 |
5,593,846 |
Premium* |
|
|
Caribou Biosciences, Inc. |
CRBU |
President and CEO, Dir... |
2024-02-20 |
158,700 |
2024-02-20 |
3,349,395 |
Premium* |
|
|
Seer, Inc. |
SEER |
Director |
2023-06-14 |
29,437 |
2022-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRBU |
Caribou Biosciences, Inc. |
President and CEO |
• • – |
2024-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
118,700 |
158,700 |
0 |
- |
|
| SEER |
Seer, Inc. |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,443 |
29,437 |
0 |
- |
|
| CRBU |
Caribou Biosciences, Inc. |
President and CEO |
• • – |
2023-06-08 |
4 |
OE |
$2.96 |
$29,600 |
D/D |
10,000 |
40,000 |
0 |
- |
|
| CRBU |
Caribou Biosciences, Inc. |
President and CEO |
• • – |
2023-03-20 |
4 |
OE |
$2.96 |
$29,600 |
D/D |
10,000 |
30,000 |
0 |
- |
|
| SEER |
Seer, Inc. |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,994 |
5,994 |
0 |
- |
|
| CRBU |
Caribou Biosciences, Inc. |
President and CEO |
• • – |
2022-05-09 |
4 |
OE |
$2.96 |
$29,600 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| CRBU |
Caribou Biosciences, Inc. |
President and CEO |
• • – |
2022-01-26 |
4 |
OE |
$2.96 |
$29,600 |
D/D |
10,000 |
3,359,395 |
0 |
- |
|
| CRBU |
Caribou Biosciences, Inc. |
President and CEO |
• • – |
2022-01-26 |
4/A |
OE |
$2.96 |
$29,600 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • • |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
I/I |
5,419,040 |
5,593,846 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
